Establishment Labs ESTA Weighted Average Exercise Price of Exercisable Options

Weighted Average Exercise Price of Exercisable Options at other companies

Globus MedicalGMED

——

Other financials

Income statement

See full

Revenue$59.9M+44.7%

Gross profit$42.3M+52.2%

Operating income-$6.5M+61.6%

Net income-$13.4M+35.4%

EPS (diluted)-$0.45+35.7%

Balance sheet

See full

Cash & equivalents$68.1M-1.6%

Total debt$252.7M+12.0%

Total equity$14.8M-61.7%

Total assets$351.0M+5.3%

Cash flow

See full

Operating cash flow-$4.3M+79.2%

CapEx$1.9M+146%

Free cash flow-$6.2M+71.3%

Valuation

See full

Market cap$2.56B+41.4%

Enterprise value$2.75B+38.7%

P/S11.2×+0.5×

Profitability

See full

Gross margin70.1%+3.7pp

Operating margin-12.4%-4.8pp

Net margin-19.1%-7.4pp

FCF margin-18.1%-6.6pp

Returns & leverage

See full

Return on equity-164%-17.8pp

Debt / equity17.1×+11.2×

Current ratio3×-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's weighted average exercise price of exercisable options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Establishment Labs's weighted average exercise price of exercisable options?: Establishment Labs (ESTA) reported weighted average exercise price of exercisable options of $50.73 in Q1 2026.
How has Establishment Labs's weighted average exercise price of exercisable options changed year-over-year?: Establishment Labs's weighted average exercise price of exercisable options increased by 11.6% year-over-year, from $45.46 to $50.73.